Azitra Inc. AZTR 深 沪
交易中 12-19 11:07:04 美东时间
0.2905
+0.006
+1.93%
华盛通- 最 高0.291
- 今 开0.2855
- 成交量 5.67万股
- 最 低 0.278
- 昨 收 0.285
- 总市值 296.45万
- 52周最高 4.329
- 市盈率 静 --
- 换手率 0.56%
- 52周最低 0.278
- 委 比 0.00%
- 总股本 1020.49万
- 历史最高 1034.964
- 量 比 0.88
- 振 幅 4.56%
- 历史最低 0.278
- 每 手 1
- 风险率 0.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Azitra Receives NYSE American Approval Of Compliance Plan, Must Regain Listing Standards By April 1, 2027
Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced it received a notice from the staff of NYSE American LLC (the
12-18 05:11
Pharma Company Azitra Shoots Down "False Report" of a $44M Stock Offering
Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it has come to the Company's attention that a report
11-07 19:06
Azitra, Inc. Addresses False Report Regarding Sale of Securities
BRANFORD, Conn., Nov. 7, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatol...
11-07 19:00
Azitra To Present Preclinical Progress For ATR-01 Program, Targeting Treatment Of Ichthyosis Vulgaris At BIO-Europe Conference
ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis vulgarisPreclinical data show production of active, functional filaggrin delivered through human stratum
10-20 20:10
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Replimune Group (NASDAQ:REPL) stock increased by 95.3% to $8.79 during...
10-20 20:08
Azitra Inc Faces NYSE Compliance Deadline Notice
Azitra Inc ( ($AZTR) ) has provided an update. On October 1, 2025, Azitra, Inc....
10-04 05:17
Azitra Receives Notice of Non-Compliance from NYSE American
BRANFORD, Conn., Oct. 3, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatol...
10-04 04:45
Azitra Stock (AZTR) Rockets on Clinical Trial Update
Azitra stock rallied on Wednesday alongside a clinical trial update.
08-27 21:25
Why Azitra Stock Shot Up 59% After-Hours?
Azitra shares surged over 58% after hours following a reverse stock split and new institutional ownership disclosure by Alumni Capital.
08-22 12:25
